Accueil   Diary - News   All news France's National Research Agency selects the OPTIVAC project

France’s National Research Agency selects the OPTIVAC project

Imaxio, a biopharmaceutical company specialized in vaccines, announced that it has been awarded a funding of EUR 600,000 (USD 772,000) by the French National Research Agency for the OPTIVAC project: "leveraging On t-cell immune resPonse To Improve influenza VACcines".

 

Read the press release

 

IMAXIO NEWSLETTER